Recombinant Human Anti-GP Antibody (1B3)
Provided is a monoclonal antibody of a human anti-Ebola virus envelope glycoprotein GP. The antibody has a unique CDR region and has a unique action site. Computer simulation analysis and biological experiments confirm that the antibody acts on the NPC1 receptor binding region of the GP, and also acts on the glycan cap region of the GP, so the antibody plays a role in the anti-Ebola virus infection through the unique neutralizing mechanism formed by the combined action of the antibody on the two structural domains of the GP. The antibody has high antigen binding activity and neutralizing activity.
| Supplier | Creative Biolabs |
|---|---|
| Product # | HPAB-N0105-YC |
| Pricing | Inquiry |
| Host | Human |
| Target | GP |
| Species Reactivity | EB0V |
| Type | Human IgG |
| Applications | ELISA, Flow Cytometry, Neutralization, Western Blot |